Clinical trial
DARE: Diabetes in cArdiac REhabilitation
NCT00354237 · Centre Hospitalier Universitaire Dijon, Other · Completed
Key facts
| NCT number | NCT00354237 |
|---|---|
| Title | DARE: Diabetes in cArdiac REhabilitation |
| Official title | Effect of Strict Glycemic Control on Improvement of Exercise Capacities (VO2 Peak, Peak Workload After Cardiac Rehabilitation, in Patients With Type 2 Diabetes Mellitus With Coronary Artery Disease. |
| Lead sponsor | Centre Hospitalier Universitaire Dijon, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus, Coronary Artery Disease |
| Intervention type | Other |
| Interventions | Conventional antidiabetic treatment, Intensive insulin treatment |
| Enrollment | 60 |
| Start date | Jul 1, 2005 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Jul 20, 2006 |
| Last update posted | Nov 18, 2014 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: